Palatin Technologies
PTN
#10644
Rank
S$18.47 M
Marketcap
S$10.38
Share price
-1.42%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$3.4 Million

According to Palatin Technologies's latest financial reports the company's total liabilities are S$3.4 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-06-30S$10.22 M-30.48%
2024-06-30S$14.7 M-45.41%
2023-06-30S$26.93 M-2.16%
2022-06-30S$27.52 M16.02%
2021-06-30S$23.72 M248.82%
2020-06-30S$6.8 M20.21%
2019-06-30S$5.65 M-65.55%
2018-06-30S$16.42 M-80.75%
2017-06-30S$85.34 M122.73%
2016-06-30S$38.31 M64.67%
2015-06-30S$23.26 M573.76%
2014-06-30S$3.45 M29.86%
2013-06-30S$2.65 M-40.87%
2012-06-30S$4.49 M22.94%
2011-06-30S$3.65 M-14.2%
2010-06-30S$4.26 M-70.14%
2009-06-30S$14.28 M-16.54%
2008-06-30S$17.11 M-54%
2007-06-30S$37.19 M7.46%
2006-06-30S$34.61 M-21.2%
2005-06-30S$43.92 M204.54%
2004-06-30S$14.42 M102.11%
2003-06-30S$7.13 M9.97%
2002-06-30S$6.48 M52.91%
2001-06-30S$4.24 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$154.66 B 4,545,554.77%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$86.08 B 2,530,069.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.93 B 56,813.72%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
S$4.26 M 25.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.69 B 20,207.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$1.11 B 32,544.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
S$3.38 M-0.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.45 B 13,413.97%๐Ÿ‡บ๐Ÿ‡ธ USA